Magnetar Financial LLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Magnetar Financial LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$7,929
-99.9%
785,8720.0%0.13%
+24.1%
Q3 2022$7,788,000
+1012.6%
785,872
+1000.9%
0.11%
+1442.9%
Q2 2022$700,00071,3820.01%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders